Age-related diseases could drive new drug market
Shifting demographics, and a new conception of aging, may stimulate new businesses
You must be signed in to read this analysis
In this article
- 'Epidemiological transition'
- Economic burdens
- Scientific re-conceptualisation
- Obstacles to development
- Policy shifts
- Export markets
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
